|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Avelino CU, Cardoso RM, Aguiar SS and
Silva MJ: Assessment of quality of life in patients with advanced
non-small cell lung carcinoma treated with a combination of
carboplatin and paclitaxel. J Bras Pneumol. 41:133–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duma N, Santana-Davila R and Molina JR:
Non-small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keskin S, Kutluk AC and Tas F: Prognostic
and predictive role of angiogenic markers in non-small cell lung
cancer. Asian Pac J Cancer Prev. 20:733–736. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martin P and Leighl NB: Review of the use
of pretest probability for molecular testing in non-small cell lung
cancer and overview of new mutations that may affect clinical
practice. Ther Adv Med Oncol. 9:405–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin H, Li P, Zhang N, Cao L, Gao YF and
Ping F: Long non-coding RNA MIR503HG serves as a tumor suppressor
in non-small cell lung cancer mediated by wnt1. Eur Rev Med
Pharmacol Sci. 23:10818–10826. 2019.PubMed/NCBI
|
|
11
|
Wang Z, Zhang J, Yang B, Li R, Jin L, Wang
Z, Yu H, Liu C, Mao Y and You Q: Long intergenic noncoding RNA
00261 acts as a tumor suppressor in non-small cell lung cancer via
regulating miR-105/FHL1 axis. J Cancer. 10:6414–6421. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shangguan WJ, Liu HT, Que ZJ, Qian FF, Liu
LS and Tian JH: TOB1-AS1 suppresses non-small cell lung cancer cell
migration and invasion through a ceRNA network. Exp Ther Med.
18:4249–4258. 2019.PubMed/NCBI
|
|
13
|
Yu L, Chen D and Song J: LncRNA SNHG16
promotes non-small cell lung cancer development through regulating
EphA2 expression by sponging miR-520a-3p. Thorac Cancer.
11:603–611. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z and Wang Y: Long non-coding RNA
FTH1P3 promotes the metastasis and aggressiveness of non-small cell
lung carcinoma by inducing epithelial-mesenchymal transition. Int J
Clin Exp Pathol. 12:3782–3790. 2019.PubMed/NCBI
|
|
15
|
Kang Y, Jia Y, Wang Q, Zhao Q, Song M, Ni
R and Wang J: Long noncoding RNA KCNQ1OT1 promotes the progression
of non-small cell lung cancer via regulating miR-204-5p/ATG3 axis.
Onco Targets Ther. 12:10787–10797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu T, Wang Y, Chen D, Liu J and Jiao W:
Potential clinical application of lncRNAs in non-small cell lung
cancer. Onco Targets Ther. 11:8045–8052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Ma L, Xu F, Zhai W, Dong S, Yin L,
Liu J and Yu Z: Role of long non-coding RNA in drug resistance in
non-small cell lung cancer. Thorac Cancer. 9:761–768. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang Y, Zhang C, Ma MH and Dai DQ:
Identification and prediction of novel non-coding and coding
RNA-associated competing endogenous RNA networks in colorectal
cancer. World J Gastroenterol. 24:5259–5270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiu BQ, Lin XH, Ye XD, Huang W, Pei X,
Xiong D, Long X, Zhu SQ, Lu F, Lin K, et al: Long non-coding RNA
PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by
modulating the miR-101/EZH2 axis as a ceRNA. Aging (Albany NY).
12:1843–1856. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abdollahzadeh R, Daraei A, Mansoori Y,
Sepahvand M, Amoli MM and Tavakkoly-Bazzaz J: Competing endogenous
RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A
new look at hallmarks of breast cancer. J Cell Physiol.
234:10080–10100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song Q, Ji Q, Xiao J, Li F, Wang L, Chen
Y, Xu Y and Jiao S: miR-409 inhibits human non-small-cell lung
cancer progression by directly targeting SPIN1. Mol Ther Nucleic
Acids. 13:154–163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abildgaard C, Do Canto LM, Steffensen KD
and Rogatto SR: Long non-coding RNAs involved in resistance to
chemotherapy in ovarian cancer. Front Oncol. 9:15492020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng
X, Xiong F, Guo C, Wu X, Li Y, et al: Emerging role of
tumor-related functional peptides encoded by lncRNA and circRNA.
Mol Cancer. 19:222020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang L, Li Z and Wang R: Long noncoding
RNAs in lung cancer: Regulation patterns, biologic function and
diagnosis implications (Review). Int J Oncol. 55:585–596.
2019.PubMed/NCBI
|
|
30
|
Li L, Wang Y, Song G, Zhang X, Gao S and
Liu H: HOX cluster-embedded antisense long non-coding RNAs in lung
cancer. Cancer Lett. 450:14–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shuwen H, Qing Z, Yan Z and Xi Y:
Competitive endogenous RNA in colorectal cancer: A systematic
review. Gene. 645:157–162. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang JX, Zeng Q, Chen L, Du JC, Yan XL,
Yuan HF, Zhai C, Zhou JN, Jia YL, Yue W and Pei XT: SPINDLIN1
promotes cancer cell proliferation through activation of WNT/TCF-4
signaling. Mol Cancer Res. 10:326–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Drago-Ferrante R, Pentimalli F, Carlisi D,
De Blasio A, Saliba C, Baldacchino S, Degaetano J, Debono J,
Caruana-Dingli G, Grech G, et al: Suppressive role exerted by
microRNA-29b-1-5p in triple negative breast cancer through SPIN1
regulation. Oncotarget. 8:28939–28958. 2017. View Article : Google Scholar : PubMed/NCBI
|
